| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 29, 2004
Accepted on February 2, 2005
12/G
13 Subunits of Heterotrimeric G Proteins Mediate Parathyroid Hormone Activation of Phospholipase D in UMR-106 Osteoblastic Cells
Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, IL, Cue BIOtech Evanston, IL, Department of Pharmacology, University of Illinois College of Medicine, Chicago, IL
* To whom correspondence should be addressed. E-mail: p-stern{at}northwestern.edu.
Parathyroid hormone (PTH), a major regulator of bone remodeling and a therapeutically effective bone anabolic agent, stimulates several signaling pathways in osteoblastic cells. Our recent studies have revealed that PTH activates phospholipase D (PLD) - mediated phospholipid hydrolysis through a
A-dependent mechanism in osteoblastic cells, raising the question of the upstream link to the PTH receptor. In the current study, we investigated the role of heterotrimeric G proteins in mediating PTH-stimulated PLD activity in UMR-106 osteoblastic cells. Transfection with antagonist minigenes coding for small peptide antagonists to G
12 and G
13 subunits of heterotrimeric G proteins prevented PTH-stimulated activation of PLD, whereas an antagonist minigene to G
s failed to produce this effect. Effects of pharmacological inhibitors (PKI, C. botulinum exoenzyme C3) were consistent with a role of
small G proteins, but not of cAMP, in the effect of PTH on PLD. Expression of constitutively active G
12 and G
13 activated PLD, an effect that was inhibited by dominant negative
A. The results identify G
12 and G
13 as upstream transducers of PTH effects on phospholipase D, mediated through RhoA in osteoblastic cells.
This article has been cited by other articles:
![]() |
S. Provot, G. Nachtrab, J. Paruch, A. P. Chen, A. Silva, and H. M. Kronenberg A-Raf and B-Raf Are Dispensable for Normal Endochondral Bone Development, and Parathyroid Hormone-Related Peptide Suppresses Extracellular Signal-Regulated Kinase Activation in Hypertrophic Chondrocytes Mol. Cell. Biol., January 1, 2008; 28(1): 344 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dean, A. Linglart, M. J. Mahon, M. Bastepe, H. Juppner, J. T. Potts Jr., and T. J. Gardella Mechanisms of Ligand Binding to the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor: Selectivity of a Modified PTH(1-15) Radioligand for G{alpha}S-Coupled Receptor Conformations Mol. Endocrinol., April 1, 2006; 20(4): 931 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Kronenberg How PTHrP Controls Growth Plate Chondrocytes IBMS BoneKEy, November 1, 2005; 2(11): 7 - 15. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |